This book examines the diagnostic overlap and frequent confusion between the newly named DSM-5 diagnostic categories of neurodevelopmental disorders (NDDs), which include autism spectrum disorder (ASD), and trauma and stressor related disorders (TSRDs). These conditions are similar in that a) children with developmental disorders are particularly vulnerable to traumatic events and b) all have pervasive effects on the brain and development. Chapters provide a wealth of effective clinical, family, and school-based interventions, developed from established studies and important new findings. In addition, chapters use illustrative case studies to survey assessment challenges in today’s healthcare climate and consider alternative routes for improving correct diagnoses, identifying appropriate interventions, and referring proper targeted, evidence-based treatment and services. The book concludes with the editors’ recommendations for needs-based service access, including a more widespread use and acceptance of the Research Domain Criteria (RDoC) and the International Classification of Functioning, Disability, and Health (ICF) framework. Topics featured in this book include: The neurobiological contributors to posttraumatic stress disorder (PTSD). Fetal alcohol spectrum disorders (FASDs) and its diagnosis in children with a history of trauma. Interventions for trauma and stressor-related disorders in preschool-aged children. Reactive attachment disorder (RAD) and autism spectrum disorder (ASD) diagnosis and care in a cultural context. Special population consideration in ASD identification and treatment. Challenges associated with the transition to adulthood. Trauma and neurodevelopmental disorders from a public health perspective. Trauma, Autism, and Neurodevelopmental Disorders is a must-have resource for researchers, clinicians and related professionals, and graduate students in developmental psychology, child and adolescent psychiatry, public health, social work, pediatrics, and special education.

Trauma, stress, and disasters are impacting our world. The scientific advances presented address the burden of disease of trauma- and stressor-related disorders. This book is about their genetic, neurochemical, developmental, and psychological foundations, epidemiology, and prevention, screening, diagnosis, and treatment. It presents evidence-based psychotherapeutic, psychopharmacological, public health, and policy interventions.

ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations) refers to the group of neurodevelopmental disorders including autism, ADHD and tic disorders as well as conditions gaining increasing awareness such as ARFID, PANS and PANDAS. Professor of child psychiatry Christopher Gillberg describes the lifetime prognosis of ESSENCE, examining the common co-occurrence between these conditions and the symptoms they present. Whilst diagnoses are often treated in isolation, Gillberg presents these issues as an overall condition, and advises treatment and support based on a holistic approach. This book also demonstrates the need for holistic whole-person interventions and assessments to improve outcomes for people within this group.

Autism spectrum disorders are developmental disorders. Individuals with autism spectrum disorders develop differently. These differences are usually present in social interaction, communication, and sensory processing, and become visible through a wide variety of behavioral responses that differ from individuals without autism spectrum disorders. Despite significant research efforts, the exact causes of autism spectrum disorders remain poorly understood; however, researchers have gained extensive insights into possible pathomechanisms, even at the molecular level of cells. Many diagnostic criteria have been developed, adapted, and improved. The eight chapters in this book highlight the current state-of-the-art in many areas of autism spectrum disorders. Chapter 1 provides an overview of the epidemiology of autism spectrum disorders and the current knowledge of the underlying pathogenic mechanisms. Chapter 2 summarizes the diagnostic criteria and procedures and highlights present and upcoming therapeutic strategies. Chapter 3 reviews the adverse events and trauma in people with autism spectrum disorders. Chapters 4 and 5 focus on atypical sensory processing, and Chapter 6 discusses the genetic overlap of autism spectrum disorders with other neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD), depression, and schizophrenia. Chapter 7 focuses on the contribution of abnormalities in mitochondria, and chapter 8 discusses gut-brain interactions and a potential role for microbiota in autism spectrum disorders. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.

This book helps clinicians harness the benefits of cognitive-behavioral therapy (CBT) for children and adolescents with high-functioning autism spectrum disorders (ASD). Leading treatment developers describe promising approaches for treating common challenges faced by young people with ASD--anxiety and behavior problems, social competence issues, and adolescent concerns around sexuality and intimacy. Chapters present session-by-session overviews of each intervention program, review its evidence base, and address practical considerations in treatment. The book also discusses general issues in adapting CBT for this population and provides a helpful framework for assessment and case conceptualization informed by DSM-5.

Neurodevelopmental disorders arise from disturbances to various processes of brain development, which can manifest in diverse ways. They encompass many rare genetic syndromes as well as common, heritable conditions such as intellectual disability, autism, ADHD, schizophrenia and many types of epilepsy. The Genetics of Neurodevelopmental Disorders examines recent revolutionary advances in our understanding of the genetics of these disorders, exploring both basic discoveries and the translation of new findings into the clinical setting. The book begins by examining the genetic architecture and etiology of neurodevelopmental disorders. It describes the striking recent progress in identifying pathogenic mutations, which are grouped here based on the neurodevelopmental processes impacted. Subsequent chapters consider the use of cellular and animal models to elucidate the cascading consequences of such mutations, from molecular and cellular levels to emergent effects on neural circuits, brain systems and subsequent psychological development. The text concludes by examining the important clinical implications of the recent advances in the field, from recognition of the genetic causes in individual patients to development of new treatments and interventions. A timely synthesis, The Genetics of Neurodevelopmental Disorders is a unique and essential resource for neuroscientists, geneticists, neurologists and psychiatrists and an accessible and up-to-date overview for medical and science students.

Homeostatic Control of Brain Function offers a broad view of brain health and diverse perspectives for potential treatments, targeting key areas such as mitochondria, the immune system, epigenetic changes, and regulatory molecules such as ions, neuropeptides, and neuromodulators. Loss of homeostasis becomes expressed as a diverse array of neurological disorders. Each disorder has multiple comorbidities - with some crossing over several conditions - and often disease-specific treatments remain elusive. When current pharmacological therapies result in ineffective and inadequate outcomes, therapies to restore and maintain homeostatic functions can help improve brain health, no matter the diagnosis. Employing homeostatic therapies may lead to future cures or treatments that address multiple comorbidities. In an age where brain diseases such as Alzheimer's or Parkinson's are ever present, the incorporation of homeostatic techniques could successfully promote better overall brain health. Key Features include · A focus on the homeostatic controls that significantly depend on the way one lives, eats, and drinks. · Highlights from emerging research in non-pharmaceutical therapies including botanical medications, meditation, diet, and exercise. · Incorporation of homeostatic therapies into existing basic and clinical research paradigms. · Extensive scientific basic and clinical research ranging from molecules to disorders. · Emerging practical information for improving homeostasis. · Examples of homeostatic therapies in preventing and delaying dysfunction. Both editors, Detlev Boison and Susan Masino, bring their unique expertise in homeostatic research to the overall scope of this work. This book is accessible to all with an interest in brain health; scientist, clinician, student, and lay reader alike.

The registered trademark symbol appears after the word DSM-5 in title.

This cutting-edge book brings advances in genetics, neurobiology, and psychopharmacology to the clinic to enhance treatment for neurodevelopmental disorders. Significant progress has been made in identifying the neurobiological mechanisms of several disorders and targeted treatments are modifying the outcome of these disorders. However, the ability to utilize this knowledge has not been summarized in one place for the practicing clinician. This book will fill that gap by providing the theoretical underpinnings and the latest advances in targeted treatments. Several neurodevelopmental disorders are reviewed in detail including clinical features and behavioral phenotypes, standard treatments and new targeted treatments based on the latest advances in neurobiology and the animal model studies that have lead to new treatments. The disorders covered include psychiatric disorders: schizophrenia, depression, autism and ADHD; single gene disorders including Tuberous Sclerosis, Fragile X Syndrome and fragile X- associated disorders, Angelman Syndrome, PKU, and Muscular Dystrophies; and complex genetic disorders such as Down syndrome. This book also highlights the commonalities across disorders and new genetic and molecular concepts in an easy to read format. This is a very exciting time for new targeted treatments and this volume is a landmark treatise on this new age of treatment.